Oxaliplatin-induced peripheral neuropathy’s effects on health-related quality of life of colorectal cancer survivors

Peripheral neurotoxicity of oxaliplatin in combination with 5-fluorouracil (FOLFOX) or capecitabine (XELOX): a prospective evaluation of 150 colorectal cancer patients

(2012) A. A. Argyriou et al.   ANNALS OF ONCOLOGY

The chemotherapy-induced peripheral neuropathy outcome measures standardization study: from consensus to the first validity and reliability findings

(2012) G. Cavaletti et al.   ANNALS OF ONCOLOGY

Clinical pattern and associations of oxaliplatin acute neurotoxicity

(2012) Andreas A. Argyriou et al.   CANCER

Development and Psychometric Evaluation of the Chemotherapy-Induced Peripheral Neuropathy Assessment Tool

(2011) Cindy S. Tofthagen et al.   CANCER NURSING

Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics

(2011) Guido Cavaletti et al.   LANCET ONCOLOGY

Intermittent versus continuous oxaliplatin and fluoropyrimidine combination chemotherapy for first-line treatment of advanced colorectal cancer: results of the randomised phase 3 MRC COIN trial

(2011) Richard A Adams et al.   LANCET ONCOLOGY

Long-Term Neuropathy After Oxaliplatin Treatment: Challenging the Dictum of Reversibility

(2011) S. B. Park et al.   ONCOLOGIST

Surviving Chemotherapy for Colon Cancer and Living with the Consequences

(2010) Cindy Tofthagen   JOURNAL OF PALLIATIVE MEDICINE

Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms

(2007) Anna-Liisa Kautio et al.   JOURNAL OF PAIN AND SYMPTOM MANAGEMENT